AstraZeneca’s diabetes med Farxiga stormed the heart failure market with a first-in-class approval last year—and in chronic kidney disease, it just left would-be rival Jardiance in the dust. The FDA late Friday approved Farxiga, also known as dapagliflozin, to treat chronic kidney disease even in patients without diabetes. With that CKD approval in hand, Farxiga… Read More »
Annastacia Palaszczuk has thrown her support behind Queensland’s resources sector one month out from the state election, green-lighting a new $ 1 billion coal mine. Penbroke’s Olive Downs project, located southwest of Mackay, will generate 1000 regional jobs. Speaking from central Queensland on Tuesday, Ms Palaszczuk dismissed calls her government hadn’t previously supported mining projects,… Read More »
According to the World Health Organization, there are 18 candidate vaccines in clinical evaluation globally. Researchers at University of Oxford said this week they have vaccinated 8,000 people in the UK as part of a Phase 3 trial. Yet there are still major hurdles to jump and more work to be done. No vaccines have… Read More »
Telling IT teams to patch vulnerabilities faster when they are already strapped for time may not help organizations get ahead of the increasing cyberthreat landscape. Similar to how an individual would not go to the dentist only once their teeth began falling out, an organization should not wait until a breach to get serious about… Read More »
As Health Data Management wraps up 27 years of reporting on the healthcare information technology industry today, it gives me a chance to pause and reflect, and to look hopefully toward the future for the industry. Much has been accomplished. I recall an early HIMSS conference at which an exhibit featured a one terabyte database… Read More »
Food and Drug Administration Commissioner Scott Gottlieb warned on Friday that if the partial government shutdown persists, it will force the FDA to make “hard decisions” on preserving key functions of the agency.